Jupiter Bioscience to raise Rs 95 cr

New Delhi, Nov 26 (UNI) Jupiter Bioscience Ltd has said its board has approved plans to raise Rs 95 crore through debt and fresh issue of equity shares to fund the capital expansion of the company and its subsidiaries.

The board also gave approval to enter into two technology inlicensing agreements with the University of California, Los Angeles.

These two technologies have been evaluated in pre-clinical trials and are related diagnostics and treatment of Helicobacter pylori (Gastritis and Peptic Ulcers), a company statement said.

UNI DKS PKS BS1618